140 related articles for article (PubMed ID: 9177468)
1. Prevention of superantigen-induced tolerance in vivo by interleukin-2 treatment.
Belfrage H; Dohlsten M; Hedlund G; Kalland T
Cancer Immunol Immunother; 1997 Apr; 44(2):77-82. PubMed ID: 9177468
[TBL] [Abstract][Full Text] [Related]
2. Enhanced and prolonged efficacy of superantigen-induced cytotoxic T lymphocyte activity by interleukin-2 in vivo.
Belfrage H; Dohlsten M; Hedlund G; Kalland T
Cancer Immunol Immunother; 1995 Aug; 41(2):87-94. PubMed ID: 7656274
[TBL] [Abstract][Full Text] [Related]
3. Immunoregulatory role of IL-10 during superantigen-induced hyporesponsiveness in vivo.
Sundstedt A; Höiden I; Rosendahl A; Kalland T; van Rooijen N; Dohlsten M
J Immunol; 1997 Jan; 158(1):180-6. PubMed ID: 8977189
[TBL] [Abstract][Full Text] [Related]
4. Superantigens anergize cytokine production but not cytotoxicity in vivo.
Sundstedt A; Dohlsten M; Hedlund G; Höidén I; Björklund M; Kalland T
Immunology; 1994 May; 82(1):117-25. PubMed ID: 7913912
[TBL] [Abstract][Full Text] [Related]
5. Effect of treatments with cyclosporin A and anti-interferon-gamma antibodies on the mechanisms of immune tolerance in staphylococcal enterotoxin B primed mice.
Kuschnaroff LM; Valckx D; Goebels J; Rutgeerts O; Heremans H; Froyent G; Waer M
Scand J Immunol; 1997 Nov; 46(5):459-68. PubMed ID: 9393628
[TBL] [Abstract][Full Text] [Related]
6. Prevention of superantigen-induced down-regulation of T-cell mediated cytotoxic activity by IL-2 in vivo.
Belfrage H; Dohlsten M; Hedlund G; Kalland T
Immunology; 1997 Feb; 90(2):183-8. PubMed ID: 9135545
[TBL] [Abstract][Full Text] [Related]
7. Combined activation of murine lymphocytes with staphylococcal enterotoxin and interleukin-2 results in additive cytotoxic activity.
Belfrage H; Bhiladvala P; Hedlund G; Dohlsten M; Kalland T
Cancer Immunol Immunother; 1994 Apr; 38(4):265-71. PubMed ID: 8168122
[TBL] [Abstract][Full Text] [Related]
8. T cells made deficient in interleukin-2 production by exposure to staphylococcal enterotoxin B in vivo are primed for interferon-gamma and interleukin-10 secretion.
Florquin S; Amraoui Z; Goldman M
Eur J Immunol; 1995 May; 25(5):1148-53. PubMed ID: 7774618
[TBL] [Abstract][Full Text] [Related]
9. Bacterial superantigens reactivate antigen-specific CD8+ memory T cells.
Coppola MA; Blackman MA
Int Immunol; 1997 Sep; 9(9):1393-403. PubMed ID: 9310843
[TBL] [Abstract][Full Text] [Related]
10. In vivo anergized CD4+ T cells express perturbed AP-1 and NF-kappa B transcription factors.
Sundstedt A; Sigvardsson M; Leanderson T; Hedlund G; Kalland T; Dohlsten M
Proc Natl Acad Sci U S A; 1996 Feb; 93(3):979-84. PubMed ID: 8577772
[TBL] [Abstract][Full Text] [Related]
11. Transforming growth factor beta 1 costimulated growth and regulatory function of staphylococcal enterotoxin B-responsive CD8+ T cells.
Rich S; Seelig M; Lee HM; Lin J
J Immunol; 1995 Jul; 155(2):609-18. PubMed ID: 7608539
[TBL] [Abstract][Full Text] [Related]
12. Administration of recombinant human IL-1 by Staphylococcus enterotoxin B prevents tolerance induction in vivo.
Nakata Y; Matsuda K; Uzawa A; Nomura M; Akashi M; Suzuki G
J Immunol; 1995 Nov; 155(9):4231-5. PubMed ID: 7594579
[TBL] [Abstract][Full Text] [Related]
13. Superantigen-induced anergy in cytotoxic CD8+ T cells.
Sundstedt A; Höidén I; Hansson J; Hedlund G; Kalland T; Dohlsten M
J Immunol; 1995 Jun; 154(12):6306-13. PubMed ID: 7759869
[TBL] [Abstract][Full Text] [Related]
14. Repeated treatment with antibody-targeted superantigens strongly inhibits tumor growth.
Rosendahl A; Kristensson K; Hansson J; Ohlsson L; Kalland T; Dohlsten M
Int J Cancer; 1998 Apr; 76(2):274-83. PubMed ID: 9537591
[TBL] [Abstract][Full Text] [Related]
15. Implantation of IL-2-containing osmotic pump prolongs the survival of superantigen-reactive T cells expanded in mice injected with bacterial superantigen.
Kuroda K; Yagi J; Imanishi K; Yan XJ; Li XY; Fujimaki W; Kato H; Miyoshi-Akiyama T; Kumazawa Y; Abe H; Uchiyama T
J Immunol; 1996 Aug; 157(4):1422-31. PubMed ID: 8759722
[TBL] [Abstract][Full Text] [Related]
16. Activation of human T cells with NK cell markers by staphylococcal enterotoxin A via IL-12 but not via IL-18.
Ami K; Ohkawa T; Koike Y; Sato K; Habu Y; Iwai T; Seki S; Hiraide H
Clin Exp Immunol; 2002 Jun; 128(3):453-9. PubMed ID: 12109440
[TBL] [Abstract][Full Text] [Related]
17. Role of interleukin-2 in superantigen-induced T-cell anergy.
Cornwell WD; Rogers TJ
Immunology; 1999 Feb; 96(2):193-201. PubMed ID: 10233695
[TBL] [Abstract][Full Text] [Related]
18. Immunopharmacology of the superantigen staphylococcal enterotoxin A in T-cell receptor V beta 3 transgenic mice.
Dohlsten M; Björklund M; Sundstedt A; Hedlund G; Samson D; Kalland T
Immunology; 1993 Aug; 79(4):520-7. PubMed ID: 7691731
[TBL] [Abstract][Full Text] [Related]
19. Superantigen-induced anergy of V beta 8+ CD4+ T cells induces functional but non-proliferative T cells in vivo.
Gaus H; Miethke T; Wagner H; Heeg K
Immunology; 1994 Nov; 83(3):333-40. PubMed ID: 7835956
[TBL] [Abstract][Full Text] [Related]
20. Superantigen-reactive T cells that display an anergic phenotype in vitro appear functional in vivo.
Heeg K; Gaus H; Griese D; Bendigs S; Miethke T; Wagner H
Int Immunol; 1995 Jan; 7(1):105-14. PubMed ID: 7718507
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
